Prostate artery embolization for benign prostatic hyperplasia: a retrospective single-center study of clinical outcome
Scandinavian Journal of Urology · 2025
DOI: 10.2340/sju.v60.44137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Urology, 2025. Verfasst von Jon Bjarnason und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Landspitali University Hospital, Reykjavik, Iceland; Department of Interventional Radiology, Landspitali University Hospital…. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Embolization, Therapeutic, Prostate, Lower Urinary Tract Symptoms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate clinical outcome and complications of prostate artery embolization (PAE) in Iceland, using the International Prostate Symptom Score (IPSS), quality of life (QoL) and catheter freedom to measure clinical success. Materials and methods: Retrospective single-center study, including patients who underwent PAE from August 2019 to February 2024 due to benign prostatic hyperplasia (BPH). Patients completed a questionnaire on lower urinary tract symptoms (LUTS), QoL, catheter status and use of medication. All additional data were retrieved from the medical records.
Results
A total of 34 patients were included, with a mean age of 75 during PAE and a technical success rate of 91%. Patients had significant clinical improvement, with a mean reduction in IPSS score from 20.0 to 9.0 (p < 0.001) and QoL score from 5.5 to 1.8 (p < 0.001). PAE also resulted in a 69% reduction (p < 0.001) in urinary catheter dependency. Post-PAE complications were uncommon (3/34) and all resolved without long-term effects.
Conclusion
PAE is an effective and safe treatment option for LUTS and/or urinary retention in men with BPH, offering catheter freedom and significant improvement in urological symptoms and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiology, Landspitali University Hospital, Reykjavik, Iceland; Department of Interventional Radiology, Landspitali University Hospital, Reykjavik, Iceland. jonbjarnason92@gmail.com.
- Department of Urology, Landspitali University Hospital, Reykjavik, Iceland.
- Department of Interventional Radiology, Landspitali University Hospital, Reykjavik, Iceland.
ORCID-Profile: Jon Bjarnason
Zitieren
APA
Bjarnason, J., Ingimarsson, J. P., Thorisson, H., Reynisson, K., Fridriksson, J. O., Kristjansson, B. T., & Bazan, F. (2025). Prostate artery embolization for benign prostatic hyperplasia: a retrospective single-center study of clinical outcome. Scandinavian Journal of Urology. https://doi.org/10.2340/sju.v60.44137
Vancouver
Bjarnason J, Ingimarsson JP, Thorisson H, Reynisson K, Fridriksson JO, Kristjansson BT, et al. Prostate artery embolization for benign prostatic hyperplasia: a retrospective single-center study of clinical outcome. Scandinavian Journal of Urology. 2025. doi:10.2340/sju.v60.44137
BibTeX
@article{Bjarnason2025,
author = {Bjarnason, Jon and Ingimarsson, Johann Pall and Thorisson, Hjalti and Reynisson, Kristbjorn and Fridriksson, Jon Orn and Kristjansson, Baldvin Thorkell and Bazan, Fernando},
title = {Prostate artery embolization for benign prostatic hyperplasia: a retrospective single-center study of clinical outcome},
journal = {Scandinavian Journal of Urology},
year = {2025},
doi = {10.2340/sju.v60.44137}
}
EUVIMED